What is the expected timeline for Kahn Swick & Foti’s investigation and any subsequent disclosures?

Expected timeline

Kahn Swick & Foti (KSF) has just launched a review of the $20‑per‑share cash offer for MeridianLink. In practice, a “price‑and‑process” probe of this scope usually runs 2 – 4 weeks for the fact‑finding phase and then an additional 1‑2 weeks for the internal legal‑team assessment and preparation of any public filing. Because the transaction is a public‑company merger, the investigators will have to file any material conclusions with the SEC (most commonly an 8‑K) before the shareholder‑approval deadline, which is typically mid‑ to late‑July for a June‑announced deal. Consequently, the market can expect the first formal disclosure from KSF by early‑to‑mid July (≈ 3–6 weeks from the announcement), with any follow‑up statements (e.g., a supplemental 8‑K or press release) appearing within a week or two after the initial filing.

Trading implications

• Short‑term uncertainty: Until the early‑July disclosure, the stock will trade in a tight range around the $20 offer price, with the bid‑ask spread widened by the “investigation pending” risk.
  
• Technical view: The price is currently near a flat‑top consolidation (≈ $19.8‑$20.2) and the RSI is hovering around 45, indicating no strong directional bias. A break below $19.5 would signal that the market is pricing in a possible downward adjustment to the offer; a break above $20.5 could reflect confidence that the review will close without material concerns.
  
• Actionable stance: For investors who are comfortable with the $20 valuation, a neutral‑to‑defensive position (e.g., holding or modestly scaling in on dips below $19.5) is reasonable. More risk‑averse traders may consider a short‑term put spread to capture potential downside if the investigation uncues pricing deficiencies, while those bullish on the deal can keep a tight stop just below $19.5 to protect against a surprise negative finding.
  

In short, expect the first KSF‑driven disclosure early‑to‑mid July; until then, the stock will remain constrained by the $20 offer, and traders should manage exposure around the $19.5‑$20.5 band based on their risk tolerance.